Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03449303 · ClinicalTrials.gov registry record · NA
Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention
A NA study, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03449303 is a NA study that has completed, run by Augusta University. The registered enrollment target is 26 participants.
The verdict
NCT03449303, a NA study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study will evaluate an oil blend with active ingredients for the reduction in chemotherapy-induced peripheral neuropathy in people with breast cancer. Half of the participants will receive the oil blend with active ingredients and the other half will receive a placebo (an oil blend with no active ingredients). One-fourth of the people will also take pictures of their life with chemotherapy-induced peripheral neuropathy.
Interventions
- OTHER Placebo
- OTHER EOI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-06-25 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03449303
The ClinicalTrials.gov registry entry for NCT03449303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03449303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03449303 about?
NCT03449303 is a clinical study titled "Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention". This study will evaluate an oil blend with active ingredients for the reduction in chemotherapy-induced peripheral neuropathy in people with breast cancer. Half of the participants will receive the oil blend with active ingredients and the other half will receive a placebo (an oil blend with no acti...
What is the current status of trial NCT03449303?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-06-25. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT03449303?
The interventions under investigation include: Placebo (OTHER), EOI (OTHER).
Who is sponsoring clinical trial NCT03449303?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.